Report Details

The report on the Global Next Generation Sequencing (NGS) Market has published by the Market Research Store. The report provides the client the latest trending insights about the Next Generation Sequencing (NGS) market. You will find in the report include market value and growth rate, size, production consumption and gross margin, pricings, and other influential factors. Along with these you will get detailed information about all the distributors, suppliers and retailers of the Next Generation Sequencing (NGS) market in the report. The competitive scenario of all the industry players are mentioned in-detail in the report. Due to the pandemic the market players have strategically changed their business plans.

Some of the key industry players that are operating in the Next Generation Sequencing (NGS) market are:

  • QIAGEN N. V.
  • Roche Holding AG
  • Eurofins Scientific
  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • Oxford Nanopore Technologies Ltd.
  • Agilent Technologies Inc.
  • Macrogen Inc.
  • PerkinElmer Inc.
  • Pacific Biosciences of California Inc.
  • GATC Biotech AG
  • BGI

Through the month of the analysis, research analysts predicted that the Next Generation Sequencing (NGS) market reached XX million dollars in 2019 and the market demand will reach XX million dollars by 2026. During the forecast period 2020 to 2026 the expected CAGR is XX%. The increasing investments in the research and development activities and the rising technological advancements in the Next Generation Sequencing (NGS) market, increasing the market growth.

Due to the increase of pandemic world-wide several market issues has generated around the world. Such as, economic crisis in various regions along with loss of employment.

The questions that are answered in the report:

  • What are the challenges for the Next Generation Sequencing (NGS) market created by the outbreak of the global pandemic?
  • What are the drivers that are shaping the Next Generation Sequencing (NGS) market?
  • What are the top opportunities that are currently ruling the market?
  • What are the segments of the Next Generation Sequencing (NGS) market that are given in the report?
  • What are the developing regions in the Next Generation Sequencing (NGS) market?

Overall industries are struggling on the global platform to revive the markets. It has been observed that through the pandemic almost every market domain has been impacted.

Market Segmentation

The Next Generation Sequencing (NGS) market regional presence is showcased in five major regions Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. In the report, the country-level analysis is also provided.

The Next Generation Sequencing (NGS) market is segmented into Product Types:

  • Whole Targeted Re-Sequencing
  • Genome Sequencing
  • De Novo Sequencing
  • Exome Sequencing
  • RNA-Seq
  • ChIP-Seq
  • Methyl-Seq

The Next Generation Sequencing (NGS) market is segmented into By End User/Application:

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Personalized Medicine
  • Agriculture and Animals Research

The major points that are covered in the report:

Overview: In this section, the global Next Generation Sequencing (NGS) Market definition is given, with an overview of the report in order to provide a board outlook about the nature and contents of the research study.

Strategies Analysis of Industry Players: This Strategic Analysis will help to gain competitive advantage over their competitors to the market players.

Essential Market Trends:  Depth analysis of the market’s latest and future trends is provided in this section.

Market Forecasts: In this segment, accurate and validated values of the total market size in terms of value and volume have provided by the research analyst. Also the report include production, consumption, sales, and other forecasts for the global Next Generation Sequencing (NGS) Market.

Regional Analysis: In the global Next Generation Sequencing (NGS) market report major five regions and its countries have been covered. Market players will have estimates about the untapped regional markets and other benefits with the help of this analysis.

Segment Analysis: Accurate and reliable foretell about the market share of the essential sections of the Next Generation Sequencing (NGS) market is provided.

Regional Segmentation

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

These dominant industry players use well planned strategies to occupied highest market share in this market. Some of the top players in Next Generation Sequencing (NGS) business includes.

  • QIAGEN N. V.
  • Roche Holding AG
  • Eurofins Scientific
  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • Oxford Nanopore Technologies Ltd.
  • Agilent Technologies Inc.
  • Macrogen Inc.
  • PerkinElmer Inc.
  • Pacific Biosciences of California Inc.
  • GATC Biotech AG
  • BGI

As per Next Generation Sequencing (NGS) market analysis, North America is forecasted to occupied major share in the Next Generation Sequencing (NGS) market.

The statistical data of the dominant industry player of Next Generation Sequencing (NGS) market can be acquired from the company profile segment described in the report. This segment come up with analysis of major player’s in the Next Generation Sequencing (NGS) market, also their last five-year revenue, segmental, product offerings, key strategies adopted and geographical revenue produced.

The report come up with a segment of the Next Generation Sequencing (NGS) market based on Type, Region, and Application, Also offer a determined view on the Next Generation Sequencing (NGS) market.

The report offers a nitty-gritty estimation of the market by providing data on various viewpoints that incorporate, restraints, drivers, and opportunities threats. This data can help in making suitable decisions for stakeholders before investing.

The sample report for Next Generation Sequencing (NGS) market can be received after the apply from the website.

Table Of Content

Table of Content 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Regulatory Scenario by Region/Country 1.4 Market Investment Scenario Strategic 1.5 Market Analysis by Type 1.5.1 Global Next Generation Sequencing (NGS) Market Share by Type (2020-2026) 1.5.2 Whole Targeted Re-Sequencing 1.5.3 Genome Sequencing 1.5.4 De Novo Sequencing 1.5.5 Exome Sequencing 1.5.6 RNA-Seq 1.5.7 ChIP-Seq 1.5.8 Methyl-Seq 1.6 Market by Application 1.6.1 Global Next Generation Sequencing (NGS) Market Share by Application (2020-2026) 1.6.2 Diagnostics 1.6.3 Drug Discovery 1.6.4 Biomarker Discovery 1.6.5 Personalized Medicine 1.6.6 Agriculture and Animals Research 1.7 Next Generation Sequencing (NGS) Industry Development Trends under COVID-19 Outbreak 1.7.1 Global COVID-19 Status Overview 1.7.2 Influence of COVID-19 Outbreak on Next Generation Sequencing (NGS) Industry Development 2. Global Market Growth Trends 2.1 Industry Trends 2.1.1 SWOT Analysis 2.1.2 Porter’s Five Forces Analysis 2.2 Potential Market and Growth Potential Analysis 2.3 Industry News and Policies by Regions 2.3.1 Industry News 2.3.2 Industry Policies 2.4 Industry Trends Under COVID-19 3 Value Chain of Next Generation Sequencing (NGS) Market 3.1 Value Chain Status 3.2 Next Generation Sequencing (NGS) Manufacturing Cost Structure Analysis 3.2.1 Production Process Analysis 3.2.2 Manufacturing Cost Structure of Next Generation Sequencing (NGS) 3.2.3 Labor Cost of Next Generation Sequencing (NGS) 3.2.3.1 Labor Cost of Next Generation Sequencing (NGS) Under COVID-19 3.3 Sales and Marketing Model Analysis 3.4 Downstream Major Customer Analysis (by Region) 3.5 Value Chain Status Under COVID-19 4 Players Profiles 4.1 QIAGEN N. V. 4.1.1 QIAGEN N. V. Basic Information 4.1.2 Next Generation Sequencing (NGS) Product Profiles, Application and Specification 4.1.3 QIAGEN N. V. Next Generation Sequencing (NGS) Market Performance (2015-2020) 4.1.4 QIAGEN N. V. Business Overview 4.2 Roche Holding AG 4.2.1 Roche Holding AG Basic Information 4.2.2 Next Generation Sequencing (NGS) Product Profiles, Application and Specification 4.2.3 Roche Holding AG Next Generation Sequencing (NGS) Market Performance (2015-2020) 4.2.4 Roche Holding AG Business Overview 4.3 Eurofins Scientific 4.3.1 Eurofins Scientific Basic Information 4.3.2 Next Generation Sequencing (NGS) Product Profiles, Application and Specification 4.3.3 Eurofins Scientific Next Generation Sequencing (NGS) Market Performance (2015-2020) 4.3.4 Eurofins Scientific Business Overview 4.4 Illumina, Inc. 4.4.1 Illumina, Inc. Basic Information 4.4.2 Next Generation Sequencing (NGS) Product Profiles, Application and Specification 4.4.3 Illumina, Inc. Next Generation Sequencing (NGS) Market Performance (2015-2020) 4.4.4 Illumina, Inc. Business Overview 4.5 Thermo Fisher Scientific Inc. 4.5.1 Thermo Fisher Scientific Inc. Basic Information 4.5.2 Next Generation Sequencing (NGS) Product Profiles, Application and Specification 4.5.3 Thermo Fisher Scientific Inc. Next Generation Sequencing (NGS) Market Performance (2015-2020) 4.5.4 Thermo Fisher Scientific Inc. Business Overview 4.6 Oxford Nanopore Technologies, Ltd. 4.6.1 Oxford Nanopore Technologies, Ltd. Basic Information 4.6.2 Next Generation Sequencing (NGS) Product Profiles, Application and Specification 4.6.3 Oxford Nanopore Technologies, Ltd. Next Generation Sequencing (NGS) Market Performance (2015-2020) 4.6.4 Oxford Nanopore Technologies, Ltd. Business Overview 4.7 Agilent Technologies, Inc. 4.7.1 Agilent Technologies, Inc. Basic Information 4.7.2 Next Generation Sequencing (NGS) Product Profiles, Application and Specification 4.7.3 Agilent Technologies, Inc. Next Generation Sequencing (NGS) Market Performance (2015-2020) 4.7.4 Agilent Technologies, Inc. Business Overview 4.8 Macrogen, Inc. 4.8.1 Macrogen, Inc. Basic Information 4.8.2 Next Generation Sequencing (NGS) Product Profiles, Application and Specification 4.8.3 Macrogen, Inc. Next Generation Sequencing (NGS) Market Performance (2015-2020) 4.8.4 Macrogen, Inc. Business Overview 4.9 PerkinElmer, Inc. 4.9.1 PerkinElmer, Inc. Basic Information 4.9.2 Next Generation Sequencing (NGS) Product Profiles, Application and Specification 4.9.3 PerkinElmer, Inc. Next Generation Sequencing (NGS) Market Performance (2015-2020) 4.9.4 PerkinElmer, Inc. Business Overview 4.10 Pacific Biosciences of California, Inc. 4.10.1 Pacific Biosciences of California, Inc. Basic Information 4.10.2 Next Generation Sequencing (NGS) Product Profiles, Application and Specification 4.10.3 Pacific Biosciences of California, Inc. Next Generation Sequencing (NGS) Market Performance (2015-2020) 4.10.4 Pacific Biosciences of California, Inc. Business Overview 4.11 GATC Biotech AG 4.11.1 GATC Biotech AG Basic Information 4.11.2 Next Generation Sequencing (NGS) Product Profiles, Application and Specification 4.11.3 GATC Biotech AG Next Generation Sequencing (NGS) Market Performance (2015-2020) 4.11.4 GATC Biotech AG Business Overview 4.12 BGI 4.12.1 BGI Basic Information 4.12.2 Next Generation Sequencing (NGS) Product Profiles, Application and Specification 4.12.3 BGI Next Generation Sequencing (NGS) Market Performance (2015-2020) 4.12.4 BGI Business Overview 5 Global Next Generation Sequencing (NGS) Market Analysis by Regions 5.1 Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share by Regions 5.1.1 Global Next Generation Sequencing (NGS) Sales by Regions (2015-2020) 5.1.2 Global Next Generation Sequencing (NGS) Revenue by Regions (2015-2020) 5.2 North America Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 5.3 Europe Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 5.4 Asia-Pacific Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 5.5 Middle East and Africa Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 5.6 South America Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 6 North America Next Generation Sequencing (NGS) Market Analysis by Countries 6.1 North America Next Generation Sequencing (NGS) Sales, Revenue and Market Share by Countries 6.1.1 North America Next Generation Sequencing (NGS) Sales by Countries (2015-2020) 6.1.2 North America Next Generation Sequencing (NGS) Revenue by Countries (2015-2020) 6.1.3 North America Next Generation Sequencing (NGS) Market Under COVID-19 6.2 United States Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 6.2.1 United States Next Generation Sequencing (NGS) Market Under COVID-19 6.3 Canada Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 6.4 Mexico Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 7 Europe Next Generation Sequencing (NGS) Market Analysis by Countries 7.1 Europe Next Generation Sequencing (NGS) Sales, Revenue and Market Share by Countries 7.1.1 Europe Next Generation Sequencing (NGS) Sales by Countries (2015-2020) 7.1.2 Europe Next Generation Sequencing (NGS) Revenue by Countries (2015-2020) 7.1.3 Europe Next Generation Sequencing (NGS) Market Under COVID-19 7.2 Germany Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 7.2.1 Germany Next Generation Sequencing (NGS) Market Under COVID-19 7.3 UK Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 7.3.1 UK Next Generation Sequencing (NGS) Market Under COVID-19 7.4 France Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 7.4.1 France Next Generation Sequencing (NGS) Market Under COVID-19 7.5 Italy Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 7.5.1 Italy Next Generation Sequencing (NGS) Market Under COVID-19 7.6 Spain Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 7.6.1 Spain Next Generation Sequencing (NGS) Market Under COVID-19 7.7 Russia Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 7.7.1 Russia Next Generation Sequencing (NGS) Market Under COVID-19 8 Asia-Pacific Next Generation Sequencing (NGS) Market Analysis by Countries 8.1 Asia-Pacific Next Generation Sequencing (NGS) Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Next Generation Sequencing (NGS) Sales by Countries (2015-2020) 8.1.2 Asia-Pacific Next Generation Sequencing (NGS) Revenue by Countries (2015-2020) 8.1.3 Asia-Pacific Next Generation Sequencing (NGS) Market Under COVID-19 8.2 China Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 8.2.1 China Next Generation Sequencing (NGS) Market Under COVID-19 8.3 Japan Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 8.3.1 Japan Next Generation Sequencing (NGS) Market Under COVID-19 8.4 South Korea Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 8.4.1 South Korea Next Generation Sequencing (NGS) Market Under COVID-19 8.5 Australia Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 8.6 India Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 8.6.1 India Next Generation Sequencing (NGS) Market Under COVID-19 8.7 Southeast Asia Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 8.7.1 Southeast Asia Next Generation Sequencing (NGS) Market Under COVID-19 9 Middle East and Africa Next Generation Sequencing (NGS) Market Analysis by Countries 9.1 Middle East and Africa Next Generation Sequencing (NGS) Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Next Generation Sequencing (NGS) Sales by Countries (2015-2020) 9.1.2 Middle East and Africa Next Generation Sequencing (NGS) Revenue by Countries (2015-2020) 9.1.3 Middle East and Africa Next Generation Sequencing (NGS) Market Under COVID-19 9.2 Saudi Arabia Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 9.3 UAE Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 9.4 Egypt Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 9.5 Nigeria Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 9.6 South Africa Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 10 South America Next Generation Sequencing (NGS) Market Analysis by Countries 10.1 South America Next Generation Sequencing (NGS) Sales, Revenue and Market Share by Countries 10.1.1 South America Next Generation Sequencing (NGS) Sales by Countries (2015-2020) 10.1.2 South America Next Generation Sequencing (NGS) Revenue by Countries (2015-2020) 10.1.3 South America Next Generation Sequencing (NGS) Market Under COVID-19 10.2 Brazil Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 10.2.1 Brazil Next Generation Sequencing (NGS) Market Under COVID-19 10.3 Argentina Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 10.4 Columbia Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 10.5 Chile Next Generation Sequencing (NGS) Sales and Growth Rate (2015-2020) 11 Global Next Generation Sequencing (NGS) Market Segment by Types 11.1 Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share by Types (2015-2020) 11.1.1 Global Next Generation Sequencing (NGS) Sales and Market Share by Types (2015-2020) 11.1.2 Global Next Generation Sequencing (NGS) Revenue and Market Share by Types (2015-2020) 11.2 Whole Targeted Re-Sequencing Sales and Price (2015-2020) 11.3 Genome Sequencing Sales and Price (2015-2020) 11.4 De Novo Sequencing Sales and Price (2015-2020) 11.5 Exome Sequencing Sales and Price (2015-2020) 11.6 RNA-Seq Sales and Price (2015-2020) 11.7 ChIP-Seq Sales and Price (2015-2020) 11.8 Methyl-Seq Sales and Price (2015-2020) 12 Global Next Generation Sequencing (NGS) Market Segment by Applications 12.1 Global Next Generation Sequencing (NGS) Sales, Revenue and Market Share by Applications (2015-2020) 12.1.1 Global Next Generation Sequencing (NGS) Sales and Market Share by Applications (2015-2020) 12.1.2 Global Next Generation Sequencing (NGS) Revenue and Market Share by Applications (2015-2020) 12.2 Diagnostics Sales, Revenue and Growth Rate (2015-2020) 12.3 Drug Discovery Sales, Revenue and Growth Rate (2015-2020) 12.4 Biomarker Discovery Sales, Revenue and Growth Rate (2015-2020) 12.5 Personalized Medicine Sales, Revenue and Growth Rate (2015-2020) 12.6 Agriculture and Animals Research Sales, Revenue and Growth Rate (2015-2020) 13 Next Generation Sequencing (NGS) Market Forecast by Regions (2020-2026) 13.1 Global Next Generation Sequencing (NGS) Sales, Revenue and Growth Rate (2020-2026) 13.2 Next Generation Sequencing (NGS) Market Forecast by Regions (2020-2026) 13.2.1 North America Next Generation Sequencing (NGS) Market Forecast (2020-2026) 13.2.2 Europe Next Generation Sequencing (NGS) Market Forecast (2020-2026) 13.2.3 Asia-Pacific Next Generation Sequencing (NGS) Market Forecast (2020-2026) 13.2.4 Middle East and Africa Next Generation Sequencing (NGS) Market Forecast (2020-2026) 13.2.5 South America Next Generation Sequencing (NGS) Market Forecast (2020-2026) 13.3 Next Generation Sequencing (NGS) Market Forecast by Types (2020-2026) 13.4 Next Generation Sequencing (NGS) Market Forecast by Applications (2020-2026) 13.5 Next Generation Sequencing (NGS) Market Forecast Under COVID-19 14 Appendix 14.1 Methodology 14.2 Research Data Source

Inquiry For Buying

Next Generation Sequencing (NGS) Market

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

Next Generation Sequencing (NGS) Market

Please fill out the form. We will contact you within 24 hours:
All fields required...

×

Avail PDF Sample Report

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you


Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com